Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00066664 · ClinicalTrials.gov registry record · NA
Serum Protein Patterns in Participants With Mycosis Fungoides/Cutaneous T-Cell Lymphoma, Psoriasis, or Normal Skin
A NA study, sponsored by National Institutes of Health Clinical Center (CC).
- Completed
- Registry status
- NA
- Development phase
- 423
- Enrollment target
NCT00066664 is a NA study that has completed, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 423 participants.
The verdict
NCT00066664, a NA study, has completed, sponsored by National Institutes of Health Clinical Center (CC).
- COMPLETED
- Registry status
- NA
- Development phase
- 423 participants
- Enrollment target
Study Summary
RATIONALE: The presence of specific serum proteins may allow a doctor to determine if a patient has mycosis fungoides/cutaneous T-cell lymphoma. PURPOSE: This clinical trial is studying how well blood protein analysis detects mycosis fungoides/cutaneous T-cell lymphoma.
Interventions
- GENETIC proteomic profiling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 423 participants |
| Start Date | 2003-06 |
| Est. Completion | 2010-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00066664
The ClinicalTrials.gov registry entry for NCT00066664 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 423 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institutes of Health Clinical Center (CC), which has 338 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which proteomic profiling is the first listed.
NCT00066664 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00066664 about?
NCT00066664 is a clinical study titled "Serum Protein Patterns in Participants With Mycosis Fungoides/Cutaneous T-Cell Lymphoma, Psoriasis, or Normal Skin". RATIONALE: The presence of specific serum proteins may allow a doctor to determine if a patient has mycosis fungoides/cutaneous T-cell lymphoma. PURPOSE: This clinical trial is studying how well blood protein analysis detects mycosis fungoides/cutaneous T-cell lymphoma.
What is the current status of trial NCT00066664?
This trial is currently completed. It is a NA study. The enrollment target is 423 participants. The study started on 2003-06. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00066664?
The interventions under investigation include: proteomic profiling (GENETIC).
Who is sponsoring clinical trial NCT00066664?
This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.